A citation-based method for searching scientific literature

Jose A Santiago, Judith A Potashkin. Trends Mol Med 2013
Times Cited: 140



Alexander Harkavyi, Amjad Abuirmeileh, Rebecca Lever, Ann E Kingsbury, Christopher S Biggs, Peter S Whitton. J Neuroinflammation 2008
Times Cited: 199




List of shared articles



Times cited

GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.
Giulia Monti, Diana Gomes Moreira, Mette Richner, Henricus Antonius Maria Mutsaers, Nelson Ferreira, Asad Jan. Cells 2022
1


Understanding the links between cardiovascular disease and Parkinson's disease.
Judy Potashkin, Xuemei Huang, Claudia Becker, Honglei Chen, Thomas Foltynie, Connie Marras. Mov Disord 2020
42

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
46


Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model.
Yanwei Li, WeiZhen Liu, Lin Li, Christian Hölscher. Neuropharmacology 2016
52


Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Henrik H Hansen, Katrine Fabricius, Pernille Barkholt, Jens D Mikkelsen, Jacob Jelsing, Charles Pyke, Lotte Bjerre Knudsen, Niels Vrang. Brain Res 2016
29